COVID-19

A discussion with a survey researcher on the 35% of US adults who state they won't get the vaccine this season.

The authorization to Moderna is the second in as many weeks for a COVID-19 vaccine, following Pfizer's.

Hepatitis B coinfection with COVID-19 did not increase either disease’s severity or increase duration of hospitalization, according to a small study in China.

Using French data, there were 3 times as many deaths from COVID-19 than the Flu in France, despite a shorter study time.

There are numerous individual and systemic barriers that preclude this vulnerable population from taking preventative measures.

Throughout the COVID-19 pandemic, the US has shown its lessening interest in mitigating the more manageable virus, influenza. Is there a chance to change course?

Those with a history of severe allergic reaction to vaccines are recommended to consider deferring on the recently approved COVID-19 vaccine.

Amputations have increased 30% among diabetic patients since the pandemic began.

Up to 83% of evaluated individuals indicated that their ocular symptoms began within two weeks of their other COVID-19 symptoms

Long-term care facility residents and healthcare workers will receive the first of millions prepared doses in the US.

The VRBPAC committee voted 17-4, with 1 abstention, to support the benefit-risk profile of BNT162b2 for preventing COVID-19 in persons aged 16 years and older.

There is concern over whether or not patients are adhering to their treatment during the pandemic.

Proactive efforts throughout the pandemic must be made to ensure this gap in primary and preventative care can be filled.

The UK’s regulatory agency is advising those with a history of severe allergies not to get vaccinated pending investigations of 2 severe adverse events.

The new findings show worsened outcomes among particular comorbid patient groups, as well as minority patients.

Faster initiation of COVID-19 treatment is associated with better outcomes in patients with hematological malignancies.

Patients with acute myeloid leukemia or myelodysplastic syndromes are at especially increased risk for increased disease severity and death.

Investigators evaluated patients from 3 Chicago hospital systems and assessed risk factors associated with thrombosis.

Diabetic patients are more susceptible to severe COVID-19 outcomes.

If approved, the vaccine may become available to the US public as early as December 21st.

Largest study of multiple health indicators over time finds widening disparities in health by race, despite increased targeted funding.

Families of patients with Dravet syndrome and other rare epileptic burdens have lived under amplified fear this year. That is why telemedicine is a more vital tool than ever.

The first case report of COVID-19 reinfection in a patient with beta thalassemia major describes absence of symptoms and two-month interval between positive PCR tests.

About 20% of 81 positive patients experienced critical neurological complications; further, half had a pre-existing history of high blood pressure or type 2 diabetes.

To date, 3 vaccine candidates with favorable safety profiles show promise in offering protection against COVID-19.

The Regeneron monoclonal antibodies are linked to reduced risk of hospitalization or ED visit among mild-to-moderate COVID-19 cases.

An interview with a pain specialist on advancing alternative pain therapy options.

C. diff infections have decreased during the ongoing pandemic.

Raymond Douglas, MD, PhD discusses how the COVID-19 pandemic has affected his clinical practice and potentially accelerated technological innovation as a whole.

Preliminary data from a phase 3 trial has met its trigger point in total COVID-19 infections, and the interim findings look good for mRNA-1273.